OTC pain relief treatments sales value in Great Britain 2009-2023

The sales value of over-the-counter (OTC) pain relief treatments in Great Britain was approximately 749 million British pounds in 2023. This was the second highest value in the provided time interval, decreasing by around one percent compared to the preceding year.

OTC medicine market in Great Britain

Pain relief was the OTC category with the highest sales value in Great Britain in 2023. Cough, cold and sore throat medication followed with a sales value of 583 million, while vitamins and minerals were the third highest at 492 million British pounds. Overall, the sales value of OTC drugs has increased from 1.65 billion British pounds in the year 2000 to being worth approximately 3.2 billion British pounds in 2023.  

Growth of other OTC categories

At some 13 percent, eye care was the OTC classification which had the highest growth of sales value in Great Britain between 2022 and 2023. This was followed by skin treatments which increased by 11 percent from 2022 to 2023.  

Sales value of OTC pain relief treatments in Great Britain from 2009 to 2023 (in million GBP)

Characteristic	Sales value in million GBP
2023	749
2022	756.1
2021	692.9
2020	658.5
2019	628.6
2018	566.5
2017	535.2
2016	576.9
2015	566.4
2014	581
2013	543.9
2012	532.7
2011	533.3
2010	530.3
2009	542.9

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

March 2024

More information

Region

United Kingdom (Great Britain)

Survey time period

2009 to 2023

Supplementary notes

Sales data is for all outlets excluding health food stores. This statistics was assembled from several PAGB annual highlights. There is no information about previous years' data being restated.

Data for 2016 covers 52 week period ending April 23, 2016.

Data from 2009 to 2013 taken from annual review's previously published by the source.

Citation formats